These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2527263)

  • 41. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine.
    Patel MB; Stewart JM; Loud AV; Anversa P; Wang J; Fiegel L; Hintze TH
    Circulation; 1991 Nov; 84(5):2091-100. PubMed ID: 1834366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-related effects of norepinephrine on rat ventricular hypertrophy.
    Hamada H; Hakamata N; Ohsuzu F; Nakamura H
    Jpn Heart J; 1997 May; 38(3):433-43. PubMed ID: 9290577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic arterial vasodilation, central hemodynamics, and cardiac hypertrophy in spontaneously hypertensive rats.
    Yuan B; Leenen FH
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):922-8. PubMed ID: 1376814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy.
    Dool JS; Mak AS; Friberg P; Wahlander H; Hawrylechko A; Adams MA
    Acta Physiol Scand; 1995 Dec; 155(4):396-404. PubMed ID: 8719259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy.
    Thomas CJ; Head GA; Woods RL
    Hypertension; 1998 Sep; 32(3):548-55. PubMed ID: 9740624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remodelling of left ventricular after banding of ascending aorta in the rat.
    Imamura M; Schluchter M; Fouad-Tarazi FM
    Cardiovasc Res; 1990 Aug; 24(8):641-6. PubMed ID: 2146017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular blood flow during aortic pressure reduction in hypertensive dogs.
    Smolich JJ; Weissberg PL; Friberg P; Broughton A; Korner PI
    Hypertension; 1991 Nov; 18(5):665-73. PubMed ID: 1834553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential role of rho-kinase in pathological and physiological cardiac hypertrophy in rats.
    Balakumar P; Singh M
    Pharmacology; 2006; 78(2):91-7. PubMed ID: 16974135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R; Young SD; Strosberg AM
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional morphology of the pressure- and the volume-hypertrophied rat heart.
    Lin HL; Katele KV; Grimm AF
    Circ Res; 1977 Dec; 41(6):830-6. PubMed ID: 144572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.
    Xiao D; Dasgupta C; Chen M; Zhang K; Buchholz J; Xu Z; Zhang L
    Cardiovasc Res; 2014 Mar; 101(3):373-82. PubMed ID: 24272874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic norepinephrine infusion and adrenergic function of hypertrophied hearts.
    Siri FM
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H485-92. PubMed ID: 3157327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy.
    Smith SH; Kramer MF; Reis I; Bishop SP; Ingwall JS
    Circ Res; 1990 Dec; 67(6):1334-44. PubMed ID: 2147129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regional differences of myocyte hypertrophy and three-dimensional deformation of the heart.
    Kuribayashi T; Furukawa K; Katsume H; Ijichi H; Ibata Y
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H378-88. PubMed ID: 2937312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats.
    Tsutsui H; Ishibashi Y; Takahashi M; Namba T; Tagawa H; Imanaka-Yoshida K; Takeshita A
    J Mol Cell Cardiol; 1999 Jun; 31(6):1203-13. PubMed ID: 10371695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.